Perinatal outcomes among women with bipolar disorder: a population-based cohort study




Materials and Methods


Data sources


We used population-level health administrative data housed at the Institute for Clinical and Evaluative Sciences (ICES) in the Province of Ontario, Canada. ICES is an independent nonprofit research organization that has the capacity to link multiple provincial administrative health databases using unique identifiers for every Ontario resident with a provincial health card number. At ICES, patient-level records are linked anonymously via the Registered Persons Database (RPDB) that contains the sex, age, postal code, and date of birth and death for all Ontario residents. Obstetric deliveries were identified using the MOMBABY dataset, which is derived from the Canadian Institute of Health Information Discharge Abstract Database (CIHI-DAD). MOMBABY captures deliveries and provides linked maternal and newborn health records for all births occurring in an Ontario hospital (>99% of deliveries). It also provides information on gestational age at birth, allowing for accurate estimation of conception date. Psychiatric admissions were captured either in the CIHI-DAD or through Ontario Mental Health Reporting System Database where admissions to designated psychiatric beds have been recorded since 2005. Diagnoses of bipolar disorder and major depressive disorder were captured within 5 years preceding the index pregnancy using the International Classification of Diseases, Ninth Revision (ICD-9) and ICD-10CA diagnoses (CIHI-DAD) and the text revision of the Diagnostic and Statistical Manual of Mental Disorders-IV diagnostic system (Ontario Mental Health Reporting System Database). Perinatal outcomes were captured during the index delivery hospitalization or on subsequent hospitalizations within 42 days after delivery, based on ICD-10CA diagnoses or Canadian Classification of Health Interventions procedure codes recorded in the CIHI-DAD. Mortality outcomes were identified through the RPDB, which identifies death arising in or outside of a hospital setting. Additional datasets used to measure study covariates included the National Ambulatory Care Reporting System Database for emergency department data, and the Ontario Health Insurance Plan Database for outpatient physician service use data. The databases used in this study have been found to be complete, reliable and accurate with respect to demographic information and primary diagnoses for inpatient services.


Participants


We identified 1,032,831 obstetric deliveries among Ontario women ages 15 to 50 years whose estimated date of conception was between April 1, 2002, and March 31, 2010. Deliveries to nonOntario residents, those with an invalid health card number and those where mother-infant matching was unsuccessful were excluded (n = 2216), as were those with a diagnosis of schizophrenia, schizoaffective disorder, or another psychotic disorder in the 5 years preceding conception (n = 1628), the focus of a previous study. We identified the 3 groups within the remaining cohort of 1,028,987 deliveries. The bipolar disorder group comprised 1859 unique women with 2124 deliveries, and who had been hospitalized for bipolar disorder within 5 years before conception in the index pregnancy (kappa = .93; 95% confidence interval [CI], 0.88–0.97). From the remaining women, we identified the major depressive disorder group which comprised 3724 unique women with 4487 deliveries, who had been hospitalized for major depressive disorder within 5 years before conception (kappa = .80; 95% CI, 0.74–0.87). Hospital-based diagnoses were required for this classification because the ability to discriminate between these 2 disorders using only outpatient service claims is likely to be poor. The reference group comprised 432,358 unique women with 553,840 deliveries, and who had no documented mental illness, that is, the absence of a hospitalization or physician service claim from a psychiatrist or family physician associated with any mental health or addictions diagnosis within the 5-year period before the index pregnancy.


Within each of the 3 exposure groups, we randomly selected 1 delivery per woman using a computer-generated randomization list.


Outcomes


The main study outcomes were: (1) PTB <37 weeks’ gestation; (2) severe small for gestational age (SGA), defined as a same-sex, same-gestational age birthweight <3rd percentile; and (3) severe large for gestational age (LGA), defined as a same-sex, same-gestational age birthweight >97th percentile. These outcomes were chosen because they are prevalent, reliably measured, and are major determinants of perinatal morbidity and mortality. As secondary outcomes, we evaluated other key perinatal health indicators: PTB <32 weeks and PTB <28 weeks’ gestation; SGA <10th percentile; LGA >90th percentile; congenital malformations; serious neonatal morbidity, comprising respiratory distress syndrome (RDS), seizure, sepsis, intraventricular hemorrhage, persistent fetal circulation, neonatal abstinence syndrome, admission to a neonatal intensive care unit, neonatal readmission to hospital <28 days, stillbirth after 20 weeks’ gestation and infant mortality <28 days, and <1 year after birth.


Covariates


Study covariates included maternal age and socioeconomic status by neighborhood income quintile and location of residence, according to each woman’s residential postal code at the time of delivery as captured by the RPDB. Prepregnancy hypertension and diabetes mellitus were captured using existing ICES disease registries. We used hospitalization data and physician service claims to capture parity and infant sex as well as problems including venous thromboembolism, and substance and/or alcohol use disorders diagnosed within the year before conception. We also measured maternal gestational diabetes, gestational hypertension, preeclampsia and other obstetric problems during the index hospitalization or within 42 days after delivery as well as mental health and reproductive health service utilization.


Statistical analyses


The distribution of covariates and outcomes for each group was described using means, medians or proportions. For all outcomes except stillbirth, only pregnancies that resulted in live births comprised the denominator of the at-risk population. Logistic regression was used to generate unadjusted and adjusted odds ratios (AORs) and 95% CIs using women with no documented mental illness as the referent. The main outcome ORs were adjusted for maternal age, income quintile, parity, infant sex, obesity, diabetes, hypertension, venous thromboembolic disease, and obstetric complications. These covariates were selected a priori as key prognostic factors that could influence outcome independently of mental health diagnosis (eg, maternal age), or could lie along the explanatory pathway between mental health diagnosis and adverse outcomes (eg, obstetric complications). Secondary outcome ORs were adjusted for maternal age and parity only to maintain appropriate covariate to event ratios, as the event rates for many of these outcomes was projected to be low. SAS version 9.2 (SAS Institute, Cary, NC) was used for all statistical analyses.


Ethics approval


Study approval was obtained from the Research Ethics Board at Women’s College Hospital (Study ID 2011-0055-E) and at Sunnybrook Health Sciences Center (ICES logged study: 2011-0584-419-000). ICES is named as a prescribed entity under Section 45(1) of Ontario’s Personal Health Information Protection Act, 2004 (PHIPA). As a requirement of having this status in PHIPA, ICES policies, practices and procedures are reviewed and approved by the Ontario Information and Privacy Commissioner. Access to raw data is governed by confidentiality agreements between ICES and independent investigators as per PHIPA guidelines. Cell sizes ≤5 are suppressed in publication according to this privacy legislation.




Results


Women with both bipolar disorder and major depressive disorder were more likely to be an adolescent than a woman without a history of mental illness, were more likely to be in the lowest income quintile, to have prepregnancy diabetes mellitus, and to have chronic hypertension ( Table 1 ). Groups did not differ with regard to the timing or frequency of prenatal care. Twenty percent (n = 391) of women with bipolar disorder and 15% (n = 557) of women with depression had been hospitalized for mental health reasons in the year before the index pregnancy, and 3.6% (n = 66) and 1.9% (n = 69) were hospitalized for psychiatric reasons during the index pregnancy, respectively.



Table 1

Baseline characteristics of 437,941 women with and without mood disorder

























































































































































































Participant characteristic
Bipolar disorder
(n = 1859)
Major depressive disorder (n = 3724) No known mental illness
(n = 432,358)
Mean (SD) age, y 26.5 (6.3) 25.3 (6.6) 29.1 (5.5)
Age <20 y 267 (14.4) 895 (24.0) 22,683 (5.2)
Age >35 y 236 (12.7) 408 (11.0) 72,540 (16.8)
Income Q
Q1 (lowest) 597 (32.2) 1195 (32.4) 101,850 (23.7)
Q2 408 (22.0) 816 (22.2) 89,281 (20.7)
Q3 325 (17.5) 685 (18.6) 86,459 (20.1)
Q4 299 (16.1) 553 (15.0) 84,682 (19.7)
Q5 (highest) 223 (12.0) 434 (11.8) 68,139 (16.8)
Urban dwelling 1625 (86.4) 3099 (83.3) 390,694 (90.4)
Primiparous 806 (43.4) 1718 (46.1) 202,255 (46.8)
Within the year preceding the index pregnancy
Obesity 44 (2.4) 79 (2.1) 5638 (1.3)
Diabetes mellitus 49 (2.6) 125 (3.4) 5108 (1.2)
Hypertension 63 (3.4) 115 (3.1) 8241 (1.9)
Venous thromboembolism 34 (1.8) 59 (1.6) 2206 (0.5)
Substance or alcohol use disorder 200 (10.9) 320 (8.60)
One or more additional psychiatric diagnoses 736 (40.0) 1106 (29.9)
Mental health hospitalization 391 (21.0) 557 (15.0)
In the index pregnancy or at delivery
Fetal ultrasound before 20 wks’ gestation 1677 (90.2) 3282 (88.1) 378,573 (87.6)
Mean (SD) number of prenatal visits 15.6 (7.9) 15.1 (7.4) 13.6 (5.8)
Gestational diabetes 78 (4.2) 127 (3.4) 20,305 (4.7)
Gestational hypertension 38 (2.0) 72 (1.9) 8466 (2.0)
Preeclampsia/eclampsia 25 (1.3) 49 (1.3) 4880 (1.1)
Thromboembolic disease 267 (14.4) 512 (13.7) 51,361 (11.9)
Placental abruption 31 (1.7) 49 (1.3) 3803 (0.9)
Placental infarction 11 (0.6) 22 (0.6) 2179 (0.5)
Septic shock ≤5 15 (0.4) 1214 (0.3)
Hemorrhage 106 (5.7) 232 (6.2) 19,303 (4.5)
Uterine rupture ≤5 ≤5 359 (0.1)
Maternal admission to ICU 19 (1.0) 27 (0.7) 1634 (0.4)
Mental health outpatient visit 1045 (56.2) 1677 (45.0) 53,054 (12.3)
Mental health emergency visit 98 (5.3) 173 (4.6) 1154 (0.3)
Mental health hospitalization 66 (3.6) 69 (1.9) 96 (0.0)

All data are presented as a number (%) unless otherwise indicated.

ICU , intensive care unit; Q , quintile; SD , standard deviation.

Mei-Dan. Perinatal outcomes with bipolar disorder. Am J Obstet Gynecol 2015 .


The prevalence of PTB was higher for women with bipolar disorder (11.4%, n = 212) and major depressive disorder (10.9%, n = 405), than the referent group (6.2%, n = 27,000). The respective AORs were 1.95 (95% CI, 1.68–2.26) and 1.91 (95% CI, 1.72–2.13) ( Table 2 ). The risk of severe SGA was not significantly elevated in the bipolar group (n = 84, 4.6%; AOR, 1.15; 95% CI, 0.92–1.43), but was so in the major depressive disorder group (n = 178, 4.8%; AOR, 1.22; 95% CI, 1.05–1.42) compared with the referent group (n = 16,823, 3.9%). Conversely, although severe LGA was significantly more common among women with bipolar disorder (n = 69, 3.8%; AOR, 1.29; 95% CI, 1.08–1.54), it was not so among women with major depressive disorder (n = 129, 3.5%; AOR, 1.15; 95% CI, 0.96–1.38).



Table 2

Main perinatal outcomes among women with bipolar or major depressive disorder





































































Perinatal outcome No known mental illness (n = 432,358) Major depressive disorder (n = 3724) Bipolar disorder (n = 1859)
Preterm birth <37 wks’ gestation
No. (%) with outcome 27,000 (6.2) 405 (10.9) 212 (11.4)
Crude OR (95% CI) 1.00 (Referent) 1.83 (1.65–2.03) 1.93 (1.67–2.23)
Adjusted OR a (95% CI) 1.00 (Referent) 1.91 (1.72–2.13) 1.95 (1.68–2.26)
Severe small for gestational age birthweight <3rd percentile
No. (%) with outcome 16,823 (3.9) 178 (4.8) 84 (4.6)
Crude OR (95% CI) 1.00 (Referent) 1.24 (1.07–1.44) 1.18 (0.95–1.47)
Adjusted OR a (95% CI) 1.00 (Referent) 1.22 (1.05–1.42) 1.15 (0.92–1.43)
Severe large for gestational age birthweight >97th percentile
No. (%) with outcome 11,712 (2.7) 129 (3.5) 69 (3.8)
Crude OR (95% CI) 1.00 (Referent) 1.31 (1.03–1.67) 1.39 (1.10–1.77)
Adjusted OR a (95% CI) 1.00 (Referent) 1.15 (0.96–1.38) 1.29 (1.08–1.54)

CI , confidence interval; OR , odds ratio.

Mei-Dan. Perinatal outcomes with bipolar disorder. Am J Obstet Gynecol 2015 .

a Adjusted for maternal age, parity, infant sex, prepregnancy obesity, substance/alcohol use disorder, diabetes mellitus, hypertension, venous thromboembolism, gestational diabetes mellitus, gestational hypertension, preeclampsia/eclampsia.



For secondary perinatal outcomes, the bipolar and major depressive disorder groups presented with similar rates of serious neonatal morbidity such as RDS, sepsis and especially neonatal abstinence syndrome, and were more likely to experience these than the referent group ( Table 3 ). Rates of congenital malformations and neonatal readmission to hospital <28 days after discharge were also higher in the mood disorder groups. The risk of stillbirth or 1-year infant mortality did not differ significantly between groups.



Table 3

Secondary perinatal outcomes among women with bipolar or major depressive disorder







































































































































































Perinatal outcome Number (%) with outcome Age- and parity-AOR
(95% CI)
No known mental illness
(n = 432,358)
Major depression
(n = 3724)
Bipolar disorder
(n = 1859)
No known mental illness
(n = 432,358)
Major depression
(n = 3724)
Bipolar disorder
(n = 1859)
Prematurity or abnormal growth
Preterm birth <32 wks 4885 (1.1) 72 (1.9) 34 (1.8) 1.00 (Referent) 1.85 (1.42–2.39) 1.70 (1.16–2.48)
Preterm birth <28 wks 2425 (0.6) 34 (0.9) 16 (0.9) 1.00 (Referent) 1.41 (0.67–2.97) 1.66 (0.92–3.02)
SGA (<10th percentile) 54,849 (12.8) 517 (14.0) 259 (14.1) 1.00 (Referent) 1.10 (1.01–1.21) 1.17 (1.03–1.34)
LGA (>90th percentile) 35,158 (8.2) 365 (9.9) 167 (9.1) 1.00 (Referent) 1.23 (1.10–1.37) 1.13 (0.96–1.32)
Neonatal morbidity
Any below a 8270 (1.9) 194 (5.4) 96 (5.4) 1.00 (Referent) 2.60 (2.24–3.03) 2.99 (2.44–3.66)
RDS 4049 (1.0) 81 (2.2) 26 (1.5) 1.00 (Referent) 2.60 (2.24–3.03) 1.64 (1.13–2.39)
Seizure 844 (0.2) 8 (0.2) 10 (0.6) 1.00 (Referent) 1.10 (0.55–2.22) 2.54 (1.31–4.90)
Sepsis 3178 (0.7) 49 (1.4) 23 (1.3) 1.00 (Referent) 1.66 (1.23–2.23) 1.80 (1.20–2.70)
IVH 1485 (0.3) 18 (0.5) 13 (0.7) 1.00 (Referent) 1.28 (0.78–2.10) 2.12 (1.22–3.67)
Persistent fetal circulation 615 (0.1) 12 (0.3) ≤5 1.00 (Referent) 1.49 (0.74–3.00) 1.89 (0.78–4.58)
Neonatal abstinence syndrome 177 (0.0) 70 (1.9) 36 (2.0) 1.00 (Referent) 45.9 (34.5–61.1) 52.2 (36.5–74.7)
Other
Stillbirth 2235 (0.5) 16 (0.4) 11 (0.6) 1.00 (Referent) 0.90 (0.55–1.47) 1.20 (0.66–2.18)
Congenital anomaly 14,963 (3.5) 174 (4.8) 90 (5.0) 1.00 (Referent) 1.37 (1.18–1.60) 1.48 (1.20–1.82)
Readmission <28 d of life 3953 (0.9) 56 (1.5) 36 (2.0) 1.00 (Referent) 1.57 (1.19–2.06) 2.41 (1.76–3.31)
Mortality <28 d of life 1004 (0.2) 7 (0.2) ≤5 1.00 (Referent) 0.84 (0.40–1.76) 0.72 (0.23–2.23)
Mortality <1 y of life 1389 (0.3) 12 (0.3) 7 (0.4) 1.00 (Referent) 0.99 (0.56–1.75) 0.99 (0.44–2.22)

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 6, 2017 | Posted by in GYNECOLOGY | Comments Off on Perinatal outcomes among women with bipolar disorder: a population-based cohort study

Full access? Get Clinical Tree

Get Clinical Tree app for offline access